Beijing Airdoc Technology Co Ltd
HKEX:2251
Intrinsic Value
Beijing Airdoc Technology Co. Ltd. engages in the provision of AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions. [ Read More ]
The intrinsic value of one Beijing Airdoc Technology Co Ltd stock under the Base Case scenario is 18.91 HKD. Compared to the current market price of 14.98 HKD, Beijing Airdoc Technology Co Ltd is Undervalued by 21%.
Valuation Backtest
Beijing Airdoc Technology Co Ltd
Run backtest to discover the historical profit from buying and selling Beijing Airdoc Technology Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Balance Sheet Decomposition
Beijing Airdoc Technology Co Ltd
Current Assets | 1.7B |
Cash & Short-Term Investments | 1.4B |
Receivables | 70.7m |
Other Current Assets | 192.2m |
Non-Current Assets | 64.1m |
Long-Term Investments | 20.3m |
PP&E | 33.1m |
Intangibles | 6.8m |
Other Non-Current Assets | 3.9m |
Current Liabilities | 64.7m |
Accounts Payable | 6.6m |
Accrued Liabilities | 27.6m |
Other Current Liabilities | 30.5m |
Non-Current Liabilities | 9.2m |
Long-Term Debt | 3.9m |
Other Non-Current Liabilities | 5.2m |
Earnings Waterfall
Beijing Airdoc Technology Co Ltd
Revenue
|
204m
CNY
|
Cost of Revenue
|
-78.8m
CNY
|
Gross Profit
|
125.1m
CNY
|
Operating Expenses
|
-314.7m
CNY
|
Operating Income
|
-189.5m
CNY
|
Other Expenses
|
57m
CNY
|
Net Income
|
-132.5m
CNY
|
Free Cash Flow Analysis
Beijing Airdoc Technology Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Beijing Airdoc Technology Co Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Beijing Airdoc Technology Co Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Beijing Airdoc Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Beijing Airdoc Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Beijing Airdoc Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Airdoc Technology Co Ltd is 20.66 HKD with a low forecast of 20 HKD and a high forecast of 21.74 HKD.
Shareholder Return
Price
Beijing Airdoc Technology Co Ltd
Average Annual Return | -53.39% |
Standard Deviation of Annual Returns | 12.79% |
Max Drawdown | -88% |
Market Capitalization | 1.6B HKD |
Shares Outstanding | 103 570 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Beijing Airdoc Technology Co. Ltd. engages in the provision of AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions. The company is headquartered in Beijing, Beijing and currently employs 369 full-time employees. The company went IPO on 2021-11-05. The firm's main product is Airdoc-AIFUNDUS 1.0. The firm's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.
Contact
IPO
Employees
Officers
The intrinsic value of one Beijing Airdoc Technology Co Ltd stock under the Base Case scenario is 18.91 HKD.
Compared to the current market price of 14.98 HKD, Beijing Airdoc Technology Co Ltd is Undervalued by 21%.